NCBiotech News

RedHill Biopharma, with U.S. headquarters in Raleigh, is reporting a 62% reduction in mortality for severe COVID-19 patients using its investigational oral pill-based therapy, opaganib.

People can now test simultaneously for COVID-19 and influenza in the safety of their own home using Labcorp’s newly approved test kit.

Cambrex Corp., a contract manufacturer of small-molecule therapeutics with major facilities in High Point and Durham, plans to invest another $30 million and hire 78 more employees to expand the production capabilities of its High Point campus.

UNC's CRISPR Genetic & Epigenetic Screening Center opens Oct. 1, with powerful new technology that received funding support from NCBiotech.

As I interviewed people who have completed the BioWork certification, and their instructors, I have learned a few things. If you have been thinking about making a career change, read on.

East Carolina University and the North Carolina Biotechnology Center are working together to bring new technologies to the marketplace.

Mayne Pharma has won an FDA OK for its topical corticosteroid LEXETTE to treat moderate to severe plaque psoriasis in patients 12 and older.

The Retinal Degeneration Fund is spinning out its own Raleigh-based biotech startup, Opus Genetics, aiming at curing blindness after landing $19 million in seed financing.

NCA&T eld a ribbon-cutting this week to officially open its new $6 million pavilion for ag research and education on its research farm in Greensboro.

After seven years as an early childhood educator, Fay-Ann Johnston found a refreshing new career opportunity through the BioWork course at Johnston Community College, leading to a good job at Novo Nordisk.

Director Dena Evans of the UNC Charlotte School of Nursing is working with partners to launch an innovative training program to prepare nurses to take healthcare to NC's rural communities.

NCA&T just got a $500,000 boost to its Aggie Commitment Trailblazer Scholars (ACTS) program, building on an initial gift of $1.5 million provided by the North Carolina GlaxoSmithKline Foundation.

NCA&T has landed a multi-million dollar award to establish “cutting-edge” research in biotechnology and materials science from the U.S. Department of Defense.

NC State and UNC are among 10 mid-Atlantic universities participating in the NSF's I-Corps Hub program that will provide entrepreneurship training to academic researchers across all fields of science and engineering so they can bring new solutions to the marketplace.

Merck is hosting a career fair this Saturday, September 18, from 10 a.m. until 1 p.m. on the grounds of St. Joseph AME Church, 2521 Fayetteville Street in Durham.